Janssen Pharmaceuticals has signed an exclusive collaboration and licence agreement with biotechnology firm Locus Biosciences for CRISPR products intended to treat bacterial infections. The partners will develop and commercialise CRISPR-Cas3-enhanced bacteriophage (crPhage) candidates that target […]
Pfizer has started a phase 2b/3 clinical trial of PF-06651600, an oral JAK3 inhibitor to treat patients with moderate to severe alopecia areata. Alopecia areata is a chronic autoimmune skin disease, which makes hair loss […]
Takeda Pharmaceutical has formed new research alliances to bolster the discovery of next-generation immunotherapies, including cell therapy techniques, for the treatment of cancer. One of the collaborations is with Memorial Sloan Kettering Cancer Center in […]
SMi Reports:In light of recent developments in the field of RNA Therapy,SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most […]
Personal invitations were sent in December 2018 from the conference chairman Mr James Drinkwater, for the 2nd Annual Pharmaceutical Microbiology East Coast Conference, taking place in Boston on April 10 and 11, with two post […]